About the Primary Peritoneal Cancer Session
Primary peritoneal cancer (PPC) is a rare malignancy closely related to epithelial ovarian cancer, originating from the peritoneum lining the abdominal cavity. Cancer research is pivotal in improving PPC outcomes, focusing on early detection, targeted therapies, and understanding genetic predispositions. Advances in genomic profiling have identified key mutations, facilitating personalized treatment approaches. Research into biomarkers is underway to develop non-invasive diagnostic tools, enhancing early detection rates. Additionally, innovative treatments like PARP inhibitors and immunotherapy are being explored to improve survival rates. Collaborative clinical trials continue to play a critical role, aiming to refine existing therapies and discover new ones, offering hope for PPC patients through cutting-edge scientific advancements.
Topics Covered in Primary Peritoneal Cancer
High-Grade Serous Histology
Tubal Origin Hypothesis
BRCA Carriers
Cytoreductive Surgery
Intraperitoneal Chemotherapy
PARP Maintenance
Related Scientific Sessions at CIOC 2027
Why Attend the Primary Peritoneal Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Primary Peritoneal Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Primary Peritoneal Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Primary Peritoneal Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Primary Peritoneal Cancer Conference 2027 — FAQs
What is the Primary Peritoneal Cancer track at CIOC 2027?
The Primary Peritoneal Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Primary Peritoneal Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Primary Peritoneal Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Primary Peritoneal Cancer are all welcome — whether presenting or attending.
Can I present my research in the Primary Peritoneal Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Primary Peritoneal Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Primary Peritoneal Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.